Invention Grant
- Patent Title: Chimeric proteins for inducing immunity towards infection with S. aureus
-
Application No.: US16319729Application Date: 2017-07-24
-
Publication No.: US11414464B2Publication Date: 2022-08-16
- Inventor: Niels Iversen Møller , Andreas Holm Mattsson , Jens Kringelum
- Applicant: Evaxion Biotech ApS
- Applicant Address: DK København K
- Assignee: Evaxion Biotech ApS
- Current Assignee: Evaxion Biotech ApS
- Current Assignee Address: DK København K
- Agency: McHale & Slavin, P.A.
- Priority: EP16180748 20160722
- International Application: PCT/EP2017/068694 WO 20170724
- International Announcement: WO2018/015575 WO 20180125
- Main IPC: A61K39/085
- IPC: A61K39/085 ; A61K39/00 ; C07K14/31 ; A61P31/04
Abstract:
Disclosed is chimeric polypeptides derived from S. aureus proteins having SEQ ID NOs: 1-9 and 139-146. The chimeric polypeptides are useful as immunogens for providing protective immunity against S. aureus infection. Also disclosed are compositions, methods of treatment and prophylaxis, nucleic acids and vectors comprising the nucleic acids.
Public/Granted literature
- US20190241623A1 Chimeric proteins for inducing immunity towards infection with S. aureus Public/Granted day:2019-08-08
Information query
